HTLV-1 infected T cells cause bone loss via small extracellular vesicles

Area of Science:

• Immunology
• Oncology
• Bone Biology

Background:

• Adult T-cell leukemia (ATL), caused by Human T-lymphotropic virus type 1 (HTLV-1), is associated with bone complications like hypercalcemia and osteolytic lesions.
• The precise mechanisms by which HTLV-1 infected cells induce bone resorption, particularly independent of RANKL, remain incompletely understood.

Purpose of the Study:

• To investigate the role of communication between HTLV-1 infected T cells and osteoclasts in mediating bone loss.
• To determine if small extracellular vesicles (sEV) derived from HTLV-1 infected cells contribute to osteolysis.

Main Methods:

• Co-culture experiments involving patient-derived ATL cells (ATL-PDX) and HTLV-1 immortalized T cell lines (HTLV/T) with osteoclast precursors.
• Analysis of cell-free supernatants and isolated sEV for osteoclast differentiation and bone resorption activity.
• Mass spectrometry and electron microscopy to characterize sEV contents, including viral proteins and bone-related factors.

Main Results:

• Supernatants from ATL-PDX and HTLV/T cells stimulated osteoclast formation, with ATL-PDX from hypercalcemic patients showing stronger effects.
• Isolated sEV from HTLV/T and ATL-PDX cells carried the osteoclast-stimulatory activity, while sEV from uninfected T cells did not.
• Active sEV contained viral Tax and Env proteins and proteins involved in osteoclastogenesis, but lacked RANKL and intact virus, demonstrating a novel osteolytic mechanism.

Conclusions:

• HTLV-1 infection induces T cells to release sEV with potent osteolytic activity, independent of RANKL.
• These sEV represent a key mechanism by which HTLV-1 infection alters the bone microenvironment and contributes to bone destruction, even without overt leukemia.